- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
Peers are launching an inquiry into private health companies paid millions of pounds to courier NHS medicines in...
Read More
Read More
Indonesia's police are conducting preliminary inquiries into whether any actions by officials at the country's drug...
Read More
Read More
Quality concerns lead to drug shortages, said Patrizia Cavazzoni, the United States Food and Drug Administration's...
Read More
Read More
The majority of the cases are type 2 diabetes, the form of the disease that is linked to obesity and largely...
Read More
Read More
The 9th edition of the International Pharma Exhibition (IPHEX), a flagship event of the Pharmaceuticals Export Promotion...
Read More
Read More
The healthcare experts discussed ways to augment healthcare capacities in India, while the academics experts discussed...
Read More
Read More
Aspirin is one of the most commonly used medications in the US. Studies show that more than 40% of adults ages 60 or...
Read More
Read More
Zydus Lifesciences Limited announced the commencement of Phase-IV Real World Data registry trial Evidences-XI for...
Read More
Read More
More than 109,000 Americans died from drug overdoses in the 12-month period ending January 2023, a slight increase from...
Read More
Read More
Biogen's (BIIB.O) shares rose 2% on Monday as a unanimous backing of its Alzheimer's drug by the U.S. health regulator's...
Read More
Read More
Novartis (NOVN.S) said it has agreed to acquire U.S. biotech firm Chinook Therapeutics (KDNY.O) for up to $3.5 billion...
Read More
Read More
AstraZeneca's lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of...
Read More
Read More